Abstracts

Impact of relative dose intensity of bevacizumab in first-line treatment of hepatocellular cancer

Background Atezolizumab-Bevacizumab (AB) is the current standard of care for treatment of unresectable hepatocellular cancer (HCC), with the recommended dosage of bevaci...

06/27/2022

Feasibility, safety, and biodistribution of 18F-BMS-986229 PET in patients with esophagogastric (EG) cancer

Background The addition of programmed cell death protein 1 (PD-1) blockade to combination cytotoxic chemotherapy improves overall survival among patients with EG cancer ...

06/27/2022

Value of liquid biopsy in faster medical decisions in colorectal cancer patients: Its clinical application in an Argentinean cancer institution

Background Time to take medical decision is very important for cancer patients. In general patients demand and require answers to understand their oncology disease. In t...

06/27/2022

Real-world outcomes in metastatic colorectal patients receiving regorafenib treatment in China

Background Regorafenib has been recognized as a standard third-line treatment in mCRC, while real-world data of large samples and treatment modalities in China are limit...

06/27/2022

Outcomes of randomized crossover trial of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma

Background Appendiceal adenocarcinoma is both a rare and heterogenous tumor, with marked contrast in the natural history of low-grade and high-grade tumors (5-year OS 68...

06/27/2022

Percentage of residual fibrosis versus Rubbia-Brandt classification as predictors of overall survival in metastatic colorectal cancer. Which is better?

Background Pathologic response to preoperative chemotherapy for colorectal liver metastases (CRLM) has been associated with survival after hepatectomy in some publicatio...

06/27/2022

Identification of serpin peptidase inhibitor clade A member 1 as a novel serum biomarker for gastric cancer and promotion of liver metastasis

Background Approximately 9. 9%～18. 7% of gastric cancer (GC) patients experience liver metastasis (LM) during the course of the disease and is highly associated with poo...

06/27/2022

Pattern of failure after radiotherapy for squamous cell carcinoma of the anus

Background Squamous cell carcinoma of the anus (SCCA) is primarily treated with radiotherapy (RT). Treatment failure is predominantly locoregional within the pelvic area...

06/27/2022

Clinico-epidemiological management of gastric adenocarcinoma. A retrospective study of 105 cases

Background The incidence of gastric cancer varies widely by country and population. The gastric cancer is the fourth most frequently occurring malignancy and the most co...

B. Abdelkader ;

F. Boudinar ;

06/27/2022

Management of gastric cancer in vulnerable patients: Is there a particularity?

Background Gastric cancer is the third leading cause of cancer death in the world and the fourth in Marrakech with an ASIR of 4.15 per 100.000 residents. It is frequentl...

06/27/2022